Short description
Intradigm Corporation is a biotechnology company developing systematic RNA interference therapeutics.
Description
Private biotechnology company that develops systematic RNA interference (RNAi) therapeutics for the treatment of serious diseases with an initial focus on oncology. The company's expertise in drug development and delivery serves as the foundation of Intradigm RNAi platform. In particular, the company proprietary RNAi Nanoplex delivery technology is unique in its ability to enable the targeted delivery of RNAi therapeutics to specific tissues through systemic administration of the drug product.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Palo Alto, California, United States, North America
Founded on
January 1, 2000
Exited on
December 16, 2009
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Noway Youcantaccess, Noaccess, No Way, Noaccess, Uh Ohhhh, Blurry Noaccess, Absolutely Noaccess, Absolutely Noaccess, Blurry Noaccess
Sign in for full access